Online ISSN: 2582-5062
Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...Review Article
Author Details :
Volume : 6, Issue : 4, Year : 2024
Article Page : 146-159
https://doi.org/10.18231/j.ctppc.2024.030
Abstract
A novel strategy in medicinal chemistry to increase the therapeutic efficacy and reduce the side effects of separate medications is the creation of mutual prodrugs. The production and pharmacological assessment of a mutual prodrug including the broad-spectrum antibiotic class fluoroquinolones and the nonsteroidal anti-inflammatory drug (NSAID) mefenamic acid are the main topics of this paper. The justification for this combination is its ability to reduce the gastrointestinal and other systemic side effects that are frequently linked to NSAIDs and fluoroquinolones, while also potentially enhancing anti-inflammatory and antibacterial activity in a synergistic manner. The chemical characteristics, production pathways, and modes of action of mefenamic acid and fluoroquinolones are thoroughly covered in this work. The design strategies for mutual prodrugs are further examined, emphasising the need to optimise reaction conditions and choose appropriate chemical linkers in order to produce a stable and potent prodrug. By contrasting the mutual prodrug with its parent molecules, a review of in vitro and in vivo research is conducted to assess the pharmacokinetic and pharmacodynamic advantages of this strategy. The paper also discusses the difficulties that arise during the synthesis and development of mutual prodrugs, such as problems with stability, bioavailability, and regulatory barriers. Future perspectives on the potential of mutual prodrugs in drug development are discussed in the paper's conclusion, which highlights the need for more study to get past present obstacles and fully realise the therapeutic benefits of this exciting approach.
Keywords: Mefenamic acid, Fluoroquinolones, Mutual prodrug, Prodrug synthesis
How to cite : Jain S, Rajpoot A D, Khare B, Soni S, Yadav R, Jain D K, Synthesis of mutual prodrug of mefenamic acid and fluroquinolones. Curr Trends Pharm Pharm Chem 2024;6(4):146-159
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.